Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study.

Evanthia BernitsasHannah KopinskySamuel Lichtman-MikolSarah RazmjouCarla Santiago-MartinezKalyan YarraguntlaFen Bao

Published in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2020)

These findings suggest a possible neuroreparative effect of fingolimod on the MS lesions and NAWM. Larger and longer randomized studies are required to confirm these results.

Keyphrases

multiple sclerosis
double blind
open label
white matter
magnetic resonance imaging
contrast enhanced
placebo controlled
phase iii
pain management
phase ii
case control
mass spectrometry
ms ms
chronic pain